Department of Biomedical Engineering
University of Texas at Austin
Austin, TX 78712-1084
E-mail : kimberlyahoman@gmail.com
Phone : 512-471-3139
Office : BME 4.408
My research focuses on the design and construction of intravenously injectable nanosystems. Once accumulated at a cancerous site, these systems can serve the dual purpose of providing therapy and imaging contrast for cancerous tissue. The nanosystems are tailored to provide enhanced contrast for photoacoustic imaging.
B.S., Chemical Engineering (physics minor), The University of Arizona, Tucson, AZ, 2000.
M.S. Biomedical Engineering, The University of Texas at Austin, Austin, TX. 2008
A. Doiron, K. Homan, S. Emelianov, L. Brannon-Peppas, “Poly(Lactic-co-Glycolic) Acid as a Carrier for Imaging Contrast Agents,” J Pharm Res, 26(3), 674-82 (2009).
A. Doiron, T. Betancourt, K. Homan and L. Brannon-Peppas, “Controlled Release and Nanotechnology,” in: Nanotechnology in Drug Delivery, M. M. de Villiers, P. Aramwit and G. S. Kwon, eds., Springer, 2008.
P. Blowers, X. Zheng, and K. Homan, “Assessment of the suitability of using the composite G2, G3, and CBS-RAD methods for predicting activation energies,” Chem Engr Commun, 190 (9), 1233-1248 (2003).